Topiramate has protective effect on renal injury
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, vol.116, no.4, pp.259-263, 2015 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 116 Issue: 4
- Publication Date: 2015
- Doi Number: 10.4149/bll_2015_050
- Journal Name: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.259-263
- Keywords: topiramate, ischemia reperfusion, kidney, carbonic anhydrase II, ISCHEMIA-REPERFUSION INJURY, CARBONIC-ANHYDRASE-III, ANTIEPILEPTIC DRUGS, CELLS, ISCHEMIA/REPERFUSION, ERYTHROPOIETIN, ANTIOXIDANT, INHIBITION
- Recep Tayyip Erdoğan University Affiliated: Yes
Abstract
Background: Topiramate (TPM) decreases tumor necrosis factor-alpha (TNF-alpha) and oxidative stress. We investigated protective effects of TPM on cell damage in kidney tissue during ischemia-reperfusion (I/R) damage.